Correlation Between Rani Therapeutics and Cabaletta Bio
Can any of the company-specific risk be diversified away by investing in both Rani Therapeutics and Cabaletta Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rani Therapeutics and Cabaletta Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rani Therapeutics Holdings and Cabaletta Bio, you can compare the effects of market volatilities on Rani Therapeutics and Cabaletta Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rani Therapeutics with a short position of Cabaletta Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rani Therapeutics and Cabaletta Bio.
Diversification Opportunities for Rani Therapeutics and Cabaletta Bio
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Rani and Cabaletta is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and Cabaletta Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabaletta Bio and Rani Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rani Therapeutics Holdings are associated (or correlated) with Cabaletta Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabaletta Bio has no effect on the direction of Rani Therapeutics i.e., Rani Therapeutics and Cabaletta Bio go up and down completely randomly.
Pair Corralation between Rani Therapeutics and Cabaletta Bio
Given the investment horizon of 90 days Rani Therapeutics Holdings is expected to under-perform the Cabaletta Bio. But the stock apears to be less risky and, when comparing its historical volatility, Rani Therapeutics Holdings is 1.72 times less risky than Cabaletta Bio. The stock trades about -0.05 of its potential returns per unit of risk. The Cabaletta Bio is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 233.00 in Cabaletta Bio on November 2, 2024 and sell it today you would earn a total of 1.00 from holding Cabaletta Bio or generate 0.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rani Therapeutics Holdings vs. Cabaletta Bio
Performance |
| Timeline |
| Rani Therapeutics |
| Cabaletta Bio |
Rani Therapeutics and Cabaletta Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rani Therapeutics and Cabaletta Bio
The main advantage of trading using opposite Rani Therapeutics and Cabaletta Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rani Therapeutics position performs unexpectedly, Cabaletta Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabaletta Bio will offset losses from the drop in Cabaletta Bio's long position.| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
| Cabaletta Bio vs. Revolution Medicines | Cabaletta Bio vs. Black Diamond Therapeutics | Cabaletta Bio vs. Passage Bio | Cabaletta Bio vs. 89bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |